Co-Diagnostics, Inc. (Nasdaq: CODX) Leads Nasdaq Top Gainers On New Saudi-Based Comira Diagnostics Joint Venture
The stock makes the Nasdaq top gainers list on news, currently trading at 0.8499 +0.4992, gaining over 142% on volume of over 534 Million shares. Prior to this news, the average volume for the stock was just over 6.5 Million shares.
News summaryCo-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics firm known for its patented Co-DxTM PCR platform, has entered into a definitive agreement with Arabian Eagle Manufacturing, a Saudi-based company, to launch a joint venture named CoMira Diagnostics. This partnership aims to localize the research, development, manufacturing, assembly, distribution, and commercialization of Co-Dx technologies across the Kingdom of Saudi Arabia (KSA) and 18 other Middle East and North Africa (MENA) countries. The initiative aligns closely with Saudi Vision 2030's priorities of technology localization, industrial diversification, and healthcare innovation, with initial regulatory efforts targeting clearance from the Saudi Food & Drug Administration (SFDA) to streamline market entry throughout the region.
Co-Diagnostics CEO Dwight Egan highlighted the venture's potential to address growing demand for point-of-care diagnostics in the MENA region, emphasizing the company's commitment to bridging accessibility gaps in high-quality PCR testing. Arabian Eagle CEO Ihssan Rjoob echoed this enthusiasm, noting how the collaboration advances health security and sustainable growth in line with national goals. No specific financial terms were disclosed in the announcement.
Full news
Research biotech and medical device/ tech stocks at Investorideas
/BIS/
Learn more about our news, PR and social media, podcast services at Investorideas
/Investors/Services
Advertising agencies -Learn more about digital advertising and guest posts at Investorideas
/Advertise/
About Investorideas - Big Investing Ideas
Investorideas is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all
Follow us on X @investorideas
Follow us on Facebook
Follow us on YouTube
Contact Investorideas
800-665-0411
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment